Profilo
Judy Chiao worked as VP-Oncology Clinical Research & Development at Aton Pharma, Inc. from 2002 to 2004.
She then worked as VP-Clinical Development & Regulatory Affairs at Cyclacel Pharmaceuticals, Inc. from 2004 to 2021.
Chiao received her undergraduate degree from The Trustees of Columbia University in The City of New York and her doctorate degree from Harvard Medical School.
Precedenti posizioni note di Judy Chiao
| Società | Posizione | Fine |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 05/03/2021 |
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Corporate Officer/Principal | 01/12/2004 |
Formazione di Judy Chiao
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Aton Pharma, Inc.
Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ. | Health Technology |
- Borsa valori
- Insiders
- Judy Chiao
